Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Cash Earnings per Share (CEPS)

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

BALAXI PHARMACEUTICALS Last 5 Year Cash Earnings per Share (CEPS) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   CEPS(Rs) 4.88-0.059.379.637.69

What is the latest Cash Earnings per Share (CEPS) ratio of BALAXI PHARMACEUTICALS ?

The latest Cash Earnings per Share (CEPS) ratio of BALAXI PHARMACEUTICALS is 4.88 based on Mar2025 Consolidated results.
Year Cash Earnings per Share (CEPS)
Mar20254.88
Mar2024-0.05
Mar20239.37
Mar20229.63
Mar20217.69

How is Cash Earnings per Share (CEPS) of BALAXI PHARMACEUTICALS Trending?

Years Cash Earnings per Share (CEPS) % Change
Mar2025 4.88
Positive
Mar2024 -0.05
Negative
Mar2023 9.37
-2.70
Mar2022 9.63
25.23
Mar2021 7.69 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare Cash Earnings per Share (CEPS) ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹97.9 Cr -1.6% -12.7% -74% Stock Analytics
ADANI ENTERPRISES ₹243,806.0 Cr -2.6% -13.8% -19.8% Stock Analytics
REDINGTON ₹16,511.1 Cr -3.7% -14% -7.7% Stock Analytics
HONASA CONSUMER ₹9,564.3 Cr 6.1% -4.2% 29.8% Stock Analytics
MMTC ₹8,544.0 Cr -5.7% -7.4% 5.4% Stock Analytics
LLOYDS ENTERPRISES ₹6,784.0 Cr -2.2% -16.7% 9.6% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-1.6%

-12.7%

-74%

SENSEX

-1.9%

-9.1%

-0.2%


You may also like the below Video Courses